Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ilse Vaneycken

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 13, 2015
PET Imaging of Macrophage Mannose Receptor-Expressing Macrophages in Tumor Stroma Using 18F-Radiolabeled Camelid Single-Domain Antibody FragmentsAnneleen Blykers, Steve Schoonooghe, Catarina Xavier, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 20, 2023
Phase I Study of [<sup>68</sup>Ga]Ga-Anti-CD206-sdAb for PET/CT Assessment of Protumorigenic Macrophage Presence in Solid Tumors (MMR Phase I)Odrade Gondry, Catarina Xavier, Laurens Raes, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 10, 2015
Phase I Study of 68Ga-HER2-Nanobody for PET/CT Assessment of HER2 Expression in Breast CarcinomaMarleen Keyaerts, Catarina Xavier, Johannes Heemskerk, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 5, 2020
Phase I Trial of <sup>131</sup>I-GMIB-Anti-HER2-VHH1, a New Promising Candidate for HER2-Targeted Radionuclide Therapy in Breast Cancer PatientsMatthias D'Huyvetter, Jens De Vos, Vicky Caveliers, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 1, 2024
Phase II Trial Assessing the Repeatability and Tumor Uptake of [<sup>68</sup>Ga]Ga-HER2 Single-Domain Antibody PET/CT in Patients with Breast CarcinomaOdrade Gondry, Vicky Caveliers, Catarina Xavier, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 13, 2015
PET Imaging of Macrophage Mannose Receptor-Expressing Macrophages in Tumor Stroma Using 18F-Radiolabeled Camelid Single-Domain Antibody FragmentsAnneleen Blykers, Steve Schoonooghe, Catarina Xavier, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 20, 2023
Phase I Study of [<sup>68</sup>Ga]Ga-Anti-CD206-sdAb for PET/CT Assessment of Protumorigenic Macrophage Presence in Solid Tumors (MMR Phase I)Odrade Gondry, Catarina Xavier, Laurens Raes, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 10, 2015
Phase I Study of 68Ga-HER2-Nanobody for PET/CT Assessment of HER2 Expression in Breast CarcinomaMarleen Keyaerts, Catarina Xavier, Johannes Heemskerk, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 5, 2020
Phase I Trial of <sup>131</sup>I-GMIB-Anti-HER2-VHH1, a New Promising Candidate for HER2-Targeted Radionuclide Therapy in Breast Cancer PatientsMatthias D'Huyvetter, Jens De Vos, Vicky Caveliers, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 1, 2024
Phase II Trial Assessing the Repeatability and Tumor Uptake of [<sup>68</sup>Ga]Ga-HER2 Single-Domain Antibody PET/CT in Patients with Breast CarcinomaOdrade Gondry, Vicky Caveliers, Catarina Xavier, et al.
Pageof 2